"The company forecast 2021 sales related to COVID-19 testing between $4.0 billion and $4.5 billion, compared with its prior outlook of $6.5 billion to $7.0 billion."
thats a reduction, I wouldn't say sales b/w $4billion and $4.5billion, as there isn't a need for testing.
yes thats BILLION Dollars !!!!
just to add to my previous list of possible ann's
-new CFO starting in a few weeks and expect Ellumes new deal to closely follow
- from the madonna king interview at 48.30 min mark
"we have got discussions going on in the UK about potentially manufacturing there and our aim supported by the Queensland government is to manufacture here."
we have heard about our in house manufacturing, nothing about UK manufacturing (TPP and UK saliva trial)
-we have mentioned several times about different readers, maybe for our multiplex covid/flu test.
what did Derek say, as a proxy of our ambition in the market, we look to Quidel and Abbot. I would be happy if Anteotech gained a fraction of Abbots market share.
ADO Price at posting:
27.0¢ Sentiment: Hold Disclosure: Held
(20min delay)